<?xml version="1.0" encoding="UTF-8"?>
<table-wrap id="Tab5">
 <label>Table 5</label>
 <caption>
  <p>DEGs identified in KEGG pathway: Cholinergic synapse. Differential expression indicates the average log
   <sub>2</sub>-fold change in RNA-Seq transcript levels from three independent experiments at each sampling period: D7 vs D0, D13 vs D7, D18 v D13, and D28 v D18. The 
   <italic>p</italic>-values were ≤ 0.001. Negative log
   <sub>2</sub>-fold change corresponds to gene downregulation and the positive values indicate gene activation
  </p>
 </caption>
 <table frame="hsides" rules="groups">
  <thead>
   <tr>
    <th colspan="4">Cholinergic synapse</th>
   </tr>
   <tr>
    <th>Gene ID</th>
    <th>Description</th>
    <th>Differential expression</th>
    <th>Time</th>
   </tr>
  </thead>
  <tbody>
   <tr>
    <td>GNG12</td>
    <td>guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-12</td>
    <td>−2.18897</td>
    <td>D0-D7</td>
   </tr>
   <tr>
    <td>CACNA1B</td>
    <td>voltage-dependent calcium channel N type alpha-1B</td>
    <td>−1.8346</td>
    <td>D0-D7</td>
   </tr>
   <tr>
    <td>KCNQ3</td>
    <td>potassium voltage-gated channel KQT-like subfamily member 3</td>
    <td>−2.96129</td>
    <td>D0-D7</td>
   </tr>
   <tr>
    <td>KCNJ12</td>
    <td>potassium inwardly-rectifying channel subfamily J member 12</td>
    <td>3.350697</td>
    <td>D0-D7</td>
   </tr>
   <tr>
    <td>CHRNA3</td>
    <td>nicotinic acetylcholine receptor alpha-3</td>
    <td>2.793838</td>
    <td>D0-D7</td>
   </tr>
   <tr>
    <td>CHRNB4</td>
    <td>nicotinic acetylcholine receptor beta-4</td>
    <td>4.925251</td>
    <td>D0-D7</td>
   </tr>
   <tr>
    <td>ITPR2</td>
    <td>inositol 1,4,5-triphosphate receptor type 2</td>
    <td>−3.69982</td>
    <td>D0-D7</td>
   </tr>
   <tr>
    <td>ITPR3</td>
    <td>inositol 1,4,5-triphosphate receptor type 3</td>
    <td>−2.4065</td>
    <td>D0-D7</td>
   </tr>
   <tr>
    <td>ADCY2</td>
    <td>adenylate cyclase 2</td>
    <td>−3.4602539</td>
    <td>D0-D7</td>
   </tr>
   <tr>
    <td>ADCY6</td>
    <td>adenylate cyclase 6</td>
    <td>1.892735</td>
    <td>D0-D7</td>
   </tr>
   <tr>
    <td>CREB5</td>
    <td>cyclic AMP-responsive element-binding protein 5</td>
    <td>2.033579</td>
    <td>D0-D7</td>
   </tr>
   <tr>
    <td>FYN</td>
    <td>tyrosine-protein kinase Fyn</td>
    <td>1.772436</td>
    <td>D0-D7</td>
   </tr>
   <tr>
    <td>CAMK4</td>
    <td>calcium/calmodulin-dependent protein kinase IV</td>
    <td>1.419104</td>
    <td>D7-D13</td>
   </tr>
   <tr>
    <td>ChAT</td>
    <td>choline O-acetyltransferase</td>
    <td>4.392642</td>
    <td>D13-D18</td>
   </tr>
   <tr>
    <td>CACNA1B</td>
    <td>voltage-dependent calcium channel N type alpha-1B</td>
    <td>1.880481</td>
    <td>D13-D18</td>
   </tr>
   <tr>
    <td>SLC5A7</td>
    <td>solute carrier family 5 (high affinity choline transporter), member 7</td>
    <td>4.94003258</td>
    <td>D13-D18</td>
   </tr>
   <tr>
    <td>KCNQ2</td>
    <td>potassium voltage-gated channel KQT-like subfamily member 2</td>
    <td>3.013059</td>
    <td>D13-D18</td>
   </tr>
   <tr>
    <td>CHRNA4</td>
    <td>nicotinic acetylcholine receptor alpha-4</td>
    <td>2.830329</td>
    <td>D13-D18</td>
   </tr>
   <tr>
    <td>CHRM3</td>
    <td>muscarinic acetylcholine receptor M3</td>
    <td>3.97881916</td>
    <td>D18-D28</td>
   </tr>
   <tr>
    <td>ChAT</td>
    <td>choline O-acetyltransferase</td>
    <td>1.799457</td>
    <td>D18-D28</td>
   </tr>
   <tr>
    <td>ACHE</td>
    <td>Acetylcholinesterase</td>
    <td>2.982588</td>
    <td>D18-D28</td>
   </tr>
   <tr>
    <td>CHRM2</td>
    <td>muscarinic acetylcholine receptor M2</td>
    <td>3.383752</td>
    <td>D18-D28</td>
   </tr>
   <tr>
    <td>SLC5A7</td>
    <td>solute carrier family 5 (high affinity choline transporter), member 7</td>
    <td>2.363264</td>
    <td>D18-D28</td>
   </tr>
   <tr>
    <td>KCNQ3</td>
    <td>potassium voltage-gated channel KQT-like subfamily member 3</td>
    <td>3.701006</td>
    <td>D18-D28</td>
   </tr>
   <tr>
    <td>CHRNA3</td>
    <td>nicotinic acetylcholine receptor alpha-3</td>
    <td>−2.67044</td>
    <td>D18-D28</td>
   </tr>
   <tr>
    <td>PRKCB</td>
    <td>classical protein kinase C beta type</td>
    <td>1.642454</td>
    <td>D18-D28</td>
   </tr>
   <tr>
    <td>ADCY2</td>
    <td>adenylate cyclase 2</td>
    <td>3.240853</td>
    <td>D18-D28</td>
   </tr>
  </tbody>
 </table>
</table-wrap>
